Concepedia

Publication | Open Access

The Mechanism of DAB2IP in Chemoresistance of Prostate Cancer Cells

DOIFull Paper Access

70

Citations

35

References

2013

Year

Kaijie Wu, Daxing Xie, Yonglong Zou, Tingting Zhang, Rey-Chen Pong, Guanghua Xiao, Ladan Fazli, Martin Gleave, Dalin He, David A. Boothman,
Clinical Cancer Research

Abstract

This study unveils a new regulation of the Egr-1/Clusterin signaling network by DAB2IP. Loss of DAB2IP expression in CRPC cells signifies their chemoresistance. Clusterin is a key target for developing more effective CRPC therapy.

References

YearCitations

Page 1